Αρχειοθήκη ιστολογίου

Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174

Παρασκευή 2 Δεκεμβρίου 2016

BOS is Associated with Increased Cytotoxic Pro-inflammatory CD8 T, NKT-like and NK Cells in the Small Airways.

wk-health-logo.gif

BACKGROUND: Immunosuppression therapy following lung transplantation fails to prevent bronchiolitis obliterans syndrome (BOS) in many patients, primarily a disease of the small airways. We have reported that BOS is associated with a lack of suppression of cytotoxic mediators, and pro-inflammatory cytokines, in peripheral blood T, NKT-like (particularly CD8+) and NK cells. We also showed a loss of glucocorticoid receptor (GCR) in pro-inflammatory lymphocytes following transplant. It is unknown whether these pro-inflammatory lymphocytes target the small and/or large airways in BOS. METHODS: Blood, bronchoalveolar lavage, large proximal and small distal airway brushings were collected from patients with BOS (n=10), stable lung transplant patients (n=18) and healthy aged-matched controls (n=10). Intracellular cytotoxic mediators (perforin/granzyme B), pro-inflammatory cytokines (IFN[gamma]/TNF[alpha]) and expression of GCR were determined in lymphocytes subsets from cultured blood using flow cytometry. RESULTS: Increases in CD8 T-cells, NKT-like cells and NK cells were found in the small distal airways in BOS compared with stable patients and controls. An increase in perforin, granzyme b, IFN[gamma], TNF[alpha] and a loss of GCR from these lymphocyte subsets was also found in BOS. GCR expression by CD8+ T cells from small airways correlated with FEV1 (R=.834, p=.039). Many of these changes significantly differed from those in the large airways. CONCLUSIONS: BOS is associated with increased cytotoxic/pro-inflammatory CD8+ T, NKT-like and NK cells in the small airways. Treatments that increase GCR in these lymphocyte subsets may improve graft survival. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.

http://ift.tt/2gTogR5

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου